KLRK1 and neoplasm: In addition, slight or no further changes were seen for the NKG2D expression, when recombinant TGF-b was added to tumor exosomes, indicating that tumor exosomes alone can maximally activate the TGF1-dependent NKG2D down-regulation pathway [23, 78].